What is Mebendazole Market?
Mebendazole is a type of medication which is used for the treatment of parasitic worm infections. The infections include ascariasis, pinworm disease, hookworm infections, guinea worm infections, hydatid disease, and giardia. It prevents newly hatched insect larvae (worms) from growing or multiplying in the body. Moreover, Mebendazole is a white to slightly yellow powder with molecular weight of 295.29. It is less than 0.05% soluble in water, dilute mineral acid solutions, alcohol, but soluble in formic acid. However, it has side effects such as headache, vomiting, and ringing in the ears.
The market study is being classified by Type (≥98% and ≥99%) and major geographies with country level break-up.
Johnson & Johnson (United States), Amneal Pharmaceuticals (United States), Cadila Pharmaceuticals (India), Eipico (Egypt), Esteve Pharmaceuticals (Spain), K A malle (India), Surya (India), GNH India (India), Changzhou Yabang-QH Pharmachem (China) and Aarambh Life Science (India) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Neha Pharma Private Limited (India), Adani Pharmachem Private Limited (India) and Shanghai Ziqi Biotechnology (China).
The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that India Players will contribute to the maximum growth of Global Mebendazole market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Mebendazole market by Type, Application and Region.
On the basis of geography, the market of Mebendazole has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Prevalence of Intestinal Infections is Fuelling the Market
- Increasing Usage of Mebendazole is Fuelling the Market
- Availability Alternative Options May Hamper the Market
- Stringent Government Regulations
- Rising Research and Developments is Boosting the Market
- Side Effects of a Mebendazole
Key Target AudienceManufacturers, Raw material suppliers, Government associations, Research organizations, Distributors and Others
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase